ABSTRACT Purpose: Childhood stuttering is common and can have debilitating, long-term psychosocial implications if prompt and effective treatment is not provided. The Lidcombe Program has robust clinical evidence for treating stuttering in early childhood. The results of a recent Phase II trial with a cohort of 6–12-year-old children showed that this treatment may benefit a much broader age range of children than initially thought. Benefits included improved communication attitudes, and reduced impact of stuttering and social anxiety symptoms. This study describes how clinicians can use the Lidcombe Program flexibly to cater to the varied needs of older children. Method: The Johnson et al. (2024) trial of the Lidcombe Program included clinical mentoring meetings every 2 weeks between the treating clinician and a member of the Lidcombe Program Trainers Consortium. Practical recommendations and clinical resources were developed to help clinicians adapt aspects of the available Lidcombe Program Treatment Guide (Onslow et al., 2021) for 6–12-year-old children. Results: Five key themes emerged from the clinical mentoring meetings to support clinicians. These included (a) active generalization of stutter-free speech to everyday conversations, (b) strategies for engaging the child in treatment, (c) examples of non-verbal contingencies, (d) optimizing treatment dosage for busy families, and (e) versatile clinical resources for different settings and child ages. Conclusions: This report provides resources for speech-language pathologists who manage school-age children who stutter. The recommendations and resources described in this report are designed to assist clinicians with adapting the Lidcombe Program for a wider age range of children.